Cargando…

Plasma Prostaglandin E(2) Metabolite Levels Predict Type 2 Diabetes Status and One-Year Therapeutic Response Independent of Clinical Markers of Inflammation

Over half of patients with type 2 diabetes (T2D) are unable to achieve blood glucose targets despite therapeutic compliance, significantly increasing their risk of long-term complications. Discovering ways to identify and properly treat these individuals is a critical problem in the field. The arach...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fenske, Rachel J., Weeks, Alicia M., Daniels, Michael, Nall, Randall, Pabich, Samantha, Brill, Allison L., Peter, Darby C., Punt, Margaret, Cox, Elizabeth D., Davis, Dawn Belt, Kimple, Michelle E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783643/ https://www.ncbi.nlm.nih.gov/pubmed/36557272 http://dx.doi.org/10.3390/metabo12121234

Ejemplares similares

The Importance of Exclusion of Obstructive Sleep Apnea During Screening for Adrenal Adenoma and Diagnosis of Pheochromocytoma
por: Weeks, Alicia C., et al.
Publicado: (2015)

Enriching Islet Phospholipids With Eicosapentaenoic Acid Reduces Prostaglandin E(2) Signaling and Enhances Diabetic β-Cell Function
por: Neuman, Joshua C., et al.
Publicado: (2017)

Dietary polyunsaturated fatty acids and their metabolites: Implications for diabetes pathophysiology, prevention, and treatment
por: Neuman, Joshua C., et al.
Publicado: (2017)

Systemic Metabolic Alterations Correlate with Islet-Level Prostaglandin E(2) Production and Signaling Mechanisms That Predict β-Cell Dysfunction in a Mouse Model of Type 2 Diabetes
por: Schaid, Michael D., et al.
Publicado: (2021)

Prostaglandin D(2) metabolite in urine is an index of food allergy
por: Maeda, Shingo, et al.
Publicado: (2017)

Spontaneous Tumor Lysis Syndrome: A Case Report and Critical Evaluation of Current Diagnostic Criteria and Optimal Treatment Regimens
por: Weeks, Alicia C., et al.
Publicado: (2015)

Association of urinary prostaglandin E2 metabolite and mortality among adults
por: Wen, Wanqing, et al.
Publicado: (2022)

Correlation between Metabolite of Prostaglandin E2 and the incidence of colorectal adenomas
por: Jiang, Jia, et al.
Publicado: (2023)

Metabolites of prostaglandin synthases as potential biomarkers of Lyme disease severity and symptom resolution
por: Jarosz, Alicia Caroline, et al.
Publicado: (2018)

Rat prostaglandin EP3 receptor is highly promiscuous and is the sole prostanoid receptor family member that regulates INS‐1 (832/3) cell glucose‐stimulated insulin secretion
por: Sandhu, Harpreet K., et al.
Publicado: (2021)

Differential Expression of Ormdl Genes in the Islets of Mice and Humans with Obesity
por: Lee, Hugo, et al.
Publicado: (2020)

Opposing effects of prostaglandin E(2) receptors EP3 and EP4 on mouse and human β-cell survival and proliferation
por: Carboneau, Bethany A., et al.
Publicado: (2017)

Lung Myofibroblasts Are Characterized by Down-Regulated Cyclooxygenase-2 and Its Main Metabolite, Prostaglandin E2
por: Gabasa, Marta, et al.
Publicado: (2013)

Release of prostaglandin D2 by murine mast cells: importance of metabolite formation for antiproliferative activity.
por: Haberl, C, et al.
Publicado: (1998)

Pyometra in Bitches Induces Elevated Plasma Endotoxin and Prostaglandin F(2α )Metabolite Levels
por: Hagman, R, et al.
Publicado: (2006)

Increased urinary prostaglandin E2 metabolite: A potential therapeutic target of Gitelman syndrome
por: Peng, Xiaoyan, et al.
Publicado: (2017)

New role for the anandamide metabolite prostaglandin F(2α) ethanolamide: Rolling preadipocyte proliferation
por: Boubertakh, Besma, et al.
Publicado: (2023)

Agonist-independent Gα(z) activity negatively regulates beta-cell compensation in a diet-induced obesity model of type 2 diabetes
por: Schaid, Michael D., et al.
Publicado: (2020)

Sodium-glucose cotransporter-2 inhibitor use in kidney transplant recipients
por: Ramakrishnan, Pavithra, et al.
Publicado: (2023)

Measurement of prostaglandin metabolites is useful in diagnosis of small bowel ulcerations
por: Matsuno, Yuichi, et al.
Publicado: (2019)

Daily Sodium Monitoring and Fluid Intake Protocol: Preventing Recurrent Hospitalization in Adipsic Diabetes Insipidus
por: Pabich, Samantha, et al.
Publicado: (2019)

Clinical Relevance of Plasma Prostaglandin F(2α) Metabolite Concentrations in Patients with Idiopathic Pulmonary Fibrosis
por: Aihara, Kensaku, et al.
Publicado: (2013)

Urinary Prostaglandin E(2) Metabolite and Pancreatic Cancer Risk: Case-Control Study in Urban Shanghai
por: Zhao, Jing, et al.
Publicado: (2015)

Prostaglandin E(2) Receptor, EP3, Is Induced in Diabetic Islets and Negatively Regulates Glucose- and Hormone-Stimulated Insulin Secretion
por: Kimple, Michelle E., et al.
Publicado: (2013)

Anti-inflammatory effects of the prostaglandin D(2)/prostaglandin DP1 receptor and lipocalin-type prostaglandin D(2) synthase/prostaglandin D(2) pathways in bacteria-induced bovine endometrial tissue
por: Wu, Jindi, et al.
Publicado: (2022)

Cloning and expression of the rabbit prostaglandin EP2 receptor
por: Guan, Youfei, et al.
Publicado: (2002)

Prostaglandin metabolite induces inhibition of TRPA1 and channel-dependent nociception
por: Weng, Yingqi, et al.
Publicado: (2012)

Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E(2)
por: Sampey, Annaleise V, et al.
Publicado: (2005)

Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer
por: Cox, D G, et al.
Publicado: (2004)

Prostaglandin D(2) metabolites as a biomarker of in vivo mast cell activation in systemic mastocytosis and rheumatoid arthritis
por: Cho, Catherine, et al.
Publicado: (2015)

Identification of a prostaglandin D(2) metabolite as a neuritogenesis enhancer targeting the TRPV1 ion channel
por: Shibata, Takahiro, et al.
Publicado: (2016)

Prostaglandin F(2α) synthase promotes oxaliplatin resistance in colorectal cancer through prostaglandin F(2α)-dependent and F(2α)-independent mechanism
por: Wang, Yi-Jun, et al.
Publicado: (2023)

Prostaglandin D(2) metabolites activate asthmatic patient-derived type 2 innate lymphoid cells and eosinophils via the DP(2) receptor
por: Carstensen, Saskia, et al.
Publicado: (2021)

Is prostaglandin E2 involved in the pathogenesis of fever? Effects of interleukin-1 on the release of prostaglandins.
por: Bernheim, H. A.
Publicado: (1986)

Age-Dependent Protection of Insulin Secretion in Diet Induced Obese Mice
por: De Leon, Elizabeth R., et al.
Publicado: (2018)

Tumor suppressor prostaglandin D(2)
por: Maeda, Shingo, et al.
Publicado: (2014)

Role of cyclooxygenase-2-mediated prostaglandin E2-prostaglandin E receptor 4 signaling in cardiac reprogramming
por: Muraoka, Naoto, et al.
Publicado: (2019)

Efficacy of prostaglandin E2 versus prostaglandin F2 alpha assisted with narrowband-UVB in stable vitiligo
por: Neinaa, Yomna Mazid El-Hamd, et al.
Publicado: (2023)

Effect of ACTH and CRH on Plasma Levels of Cortisol and Prostaglandin F(2α )Metabolite in Cycling Gilts and Castrated Boars
por: Madej, A, et al.
Publicado: (2005)

Prostaglandin-E(2) is produced by adult human epidermal melanocytes in response to UVB in a melanogenesis-independent manner
por: Gledhill, Karl, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_du326q1av2mh0ltdq97olj5ceh